Shares of Predictive Oncology Inc. (POAI) are soaring above 50% in pre-market today, after the company announced that it would launch a new AI platform for vaccine and drug development targeting Coronaviruses and Acute Respiratory Syndromes (COVID-19, MERS, and SARS) through an operating agreement with Soluble Therapeutics.
from RTT - Before the Bell https://ift.tt/3cSa74G
via IFTTT
No comments:
Post a Comment